Development of a Targeted Multi-Disorder High-Throughput Sequencing Assay for the Effective Identification of Disease-Causing Variants.
about
Development and validation of a targeted next generation DNA sequencing panel outperforming whole exome sequencing for the identification of clinically relevant genetic variants.Genomic medicine for kidney disease.Compound heterozygous CASQ2 mutations and long-term course of catecholaminergic polymorphic ventricular tachycardia.Mutation load estimation model as a predictor of the response to cancer immunotherapy.
P2860
Development of a Targeted Multi-Disorder High-Throughput Sequencing Assay for the Effective Identification of Disease-Causing Variants.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Development of a Targeted Mult ...... n of Disease-Causing Variants.
@ast
Development of a Targeted Mult ...... n of Disease-Causing Variants.
@en
type
label
Development of a Targeted Mult ...... n of Disease-Causing Variants.
@ast
Development of a Targeted Mult ...... n of Disease-Causing Variants.
@en
prefLabel
Development of a Targeted Mult ...... n of Disease-Causing Variants.
@ast
Development of a Targeted Mult ...... n of Disease-Causing Variants.
@en
P2093
P2860
P1433
P1476
Development of a Targeted Mult ...... on of Disease-Causing Variants
@en
P2093
Alex Maslov
Cristina Montagna
Evan M Cadoff
John M Greally
Kunjan Patel
Maria Delio
Robert W Marion
Thomas V McDonald
P2860
P304
P356
10.1371/JOURNAL.PONE.0133742
P407
P577
2015-07-27T00:00:00Z